ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
ASKA Pharmaceutical Holdings Co Ltd
Net Income (Common)
ASKA Pharmaceutical Holdings Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
87%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income (Common)
¥178.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income (Common)
¥186.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
23%
|
CAGR 10-Years
5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income (Common)
¥121.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income (Common)
¥325.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
20%
|
|
Astellas Pharma Inc
TSE:4503
|
Net Income (Common)
¥37.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
See Also
What is ASKA Pharmaceutical Holdings Co Ltd's Net Income (Common)?
Net Income (Common)
4.2B
JPY
Based on the financial report for Mar 31, 2023, ASKA Pharmaceutical Holdings Co Ltd's Net Income (Common) amounts to 4.2B JPY.
What is ASKA Pharmaceutical Holdings Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
12%
Over the last year, the Net Income (Common) growth was -1%. The average annual Net Income (Common) growth rates for ASKA Pharmaceutical Holdings Co Ltd have been 87% over the past three years , 12% over the past five years .